Loading...

Nanosonics Limited

NAN.AX•ASX
Healthcare
Medical - Instruments & Supplies
A$4.73
A$0.68(16.79%)

Nanosonics Limited (NAN.AX) Stock Overview

Explore Nanosonics Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap1.2B
P/E Ratio76.64
EPS (TTM)$0.05
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Week$4.22
1 Month$4.33
3 Months$4.92
1 Year Target$3.57

NAN.AX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Nanosonics Limited (NAN.AX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 55.33, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $3.57.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 76.64 and a market capitalization of 1.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
4.10%
5-Day Change
2.77%
1-Month Change
8.56%
3-Month Change
54.98%
6-Month Change
34.26%
Year-to-Date (YTD) Change
60.13%
1-Year Change
70.32%
3-Year Change
24.55%
5-Year Change
-22.76%
All-Time (Max) Change
487.80%

Contact Information

https://www.nanosonics.com.au
61 2 8063 1600
Building A, Macquarie Park, NSW, 2113

Company Facts

466 Employees
IPO DateMay 17, 2007
CountryAU
Actively Trading

Frequently Asked Questions

;